Articles liés à Real-World Evidence in Drug Development and Evaluation
Synopsis
This book concerns use of real world data (RWD) and real world evidence (RWE) to aid drug development across product cycle. RWD are healthcare data that are collected outside the constraints of conventual controlled randomized trials (CRTs); whereas RWE is the knowledge derived from aggregation and analysis of RWD.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
À propos de l?auteur
Harry Yang, Ph.D., is Vice President and Head of Biometrics at Fate Therapeutics. He has 25 years of experience across all aspects of drug research and development, from early target discovery, through pre-clinical, clinical, and CMC programs to regulatory approval and post-approval lifecycle management. He has published 7 statistical books, 15 book chapters, and over 90 peer-reviewed papers on diverse scientific and statistical subjects. He is a frequent invited speaker at national and international conferences. He also developed statistical courses and conducted training at the FDA and USP.
Binbing Yu, Ph.D., is Associate Director in the Oncology Statistical Innovation group at AstraZeneca. He serves as the statistical expert across the whole spectrum of drug R&D, including drug discovery, clinical trials, operation and manufacturing, clinical pharmacology, oncology medical affairs and post-marketing surveillance. He obtained his PhD in Statistics from the George Washington University. His primary research interests are clinical trial design and analysis, cancer epidemiology, causal inference in observation studies, PKPD modeling and Bayesian analysis.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
- ÉditeurChapman and Hall/CRC
- Date d'édition2022
- ISBN 10 0367637014
- ISBN 13 9780367637019
- ReliureBroché
- Langueanglais
- Nombre de pages190
- ÉditeurYang Harry, Yu Binbing
- Coordonnées du fabricantnon disponible
Acheter neuf
Afficher cet article
EUR 61,06
EUR 4,81 expédition depuis Royaume-Uni vers France
Destinations, frais et délais
Résultats de recherche pour Real-World Evidence in Drug Development and Evaluation
Image d'archives
Real-World Evidence in Drug Development and Evaluation
Edité par
Taylor & Francis Ltd, 2022
ISBN 10 : 0367637014
ISBN 13 : 9780367637019
Neuf
Paperback / softback
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback / softback. Etat : New. New copy - Usually dispatched within 4 working days. 185. N° de réf. du vendeur B9780367637019
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Real-World Evidence in Drug Development and Evaluation
impression à la demandeVendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Harry Yang, Ph.D., is Vice President and Head of Biometrics at Fate Therapeutics. He has 25 years of experience across all aspects of drug research and development, from early target discovery, through pre-clinical, clinical, and CMC pro. N° de réf. du vendeur 842314163
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Real-World Evidence in Drug Development and Evaluation
Edité par
Taylor & Francis Ltd Aug 2022, 2022
ISBN 10 : 0367637014
ISBN 13 : 9780367637019
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.FeaturesProvides the first book and a single source of information on RWE in drug developmentCovers a broad array of topics on outcomes- and value-based RWE assessments Demonstrates proper Bayesian application and causal inference for real-world data (RWD)Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insightsOffers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise 178 pp. Englisch. N° de réf. du vendeur 9780367637019
Quantité disponible : 2 disponible(s)
Image d'archives
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Edité par
Chapman and Hall/CRC, 2022
ISBN 10 : 0367637014
ISBN 13 : 9780367637019
Neuf
Couverture souple
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur 401655685
Quantité disponible : 3 disponible(s)
Image d'archives
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Edité par
Chapman and Hall/CRC, 2022
ISBN 10 : 0367637014
ISBN 13 : 9780367637019
Neuf
Couverture souple
Vendeur : California Books, Miami, FL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur I-9780367637019
Quantité disponible : Plus de 20 disponibles
Image d'archives
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Edité par
Chapman and Hall/CRC, 2022
ISBN 10 : 0367637014
ISBN 13 : 9780367637019
Neuf
Couverture souple
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9780367637019_new
Quantité disponible : Plus de 20 disponibles
Image d'archives
Real-world Evidence in Drug Development and Evaluation
Edité par
Chapman and Hall/CRC, 2022
ISBN 10 : 0367637014
ISBN 13 : 9780367637019
Ancien ou d'occasion
Couverture souple
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 44651855
Quantité disponible : Plus de 20 disponibles
Image d'archives
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Edité par
Chapman and Hall/CRC, 2022
ISBN 10 : 0367637014
ISBN 13 : 9780367637019
Neuf
Couverture souple
Vendeur : Books Puddle, New York, NY, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. 1st edition NO-PA16APR2015-KAP. N° de réf. du vendeur 26394754138
Quantité disponible : 4 disponible(s)
Image fournie par le vendeur
Real-World Evidence in Drug Development and Evaluation
impression à la demandeVendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.FeaturesProvides the first book and a single source of information on RWE in drug developmentCovers a broad array of topics on outcomes- and value-based RWE assessments Demonstrates proper Bayesian application and causal inference for real-world data (RWD)Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insightsOffers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise. N° de réf. du vendeur 9780367637019
Quantité disponible : 1 disponible(s)
Image d'archives
Real-World Evidence in Drug Development and Evaluation
impression à la demandeVendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9780367637019
Quantité disponible : Plus de 20 disponibles